Cancer cells plasticity and drug resistance
29 Apr 2016
Cancer cells plasticity and drug resistance
Targeted therapy shows continued promise in patients whose tumours had NTRK gene fusions
Editor's Choice for April 2016
Drugging “undruggable” transcription factor drivers in cancer
Combination therapy before surgery improves outcomes for patients with HER2 positive breast cancer
Identifying myeloid-driven biologies
New technology can potentially overcome CAR T-cell limitations
AML during pregancy
Germ line predisposition to leukaemia
The future of haematopathology
Frontline therapy in young patients with myeloma
Genomics of childhood ALL